Leucine facilitates the insulin-stimulated glucose uptake and insulin signaling in skeletal muscle cells: Involving mTORC1 and mTORC2

Amino Acids

Volumn 46, Issue 8, 2014, Pages 1971-1979

  Liu, Hui ^a   Liu, Rui ^c   Xiong, Yufang ^b   Li, Xiang ^a   Wang, Xiaolei ^a   Ma, Yan ^a   Guo, Huailan ^c   Hao, Liping ^a   Yao, Ping ^a   Liu, Liegang ^a   Wang, Di ^a   Yang, Xuefeng ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c HUBEI UNIVERSITY OF MEDICINE   (China)

Author keywords

Glucose uptake; Insulin signaling; Leucine; Mammalian target of rapamycin

Indexed keywords

INSULIN; LEUCINE; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; PROTEIN KINASE B; RAPAMYCIN; SMALL INTERFERING RNA; WORTMANNIN; ANDROSTANE DERIVATIVE; CARRIER PROTEIN; GLUCOSE; HYPERGLYCEMIC AGENT; MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1; MULTIPROTEIN COMPLEX; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE INHIBITOR; RICTOR PROTEIN, RAT; TARGET OF RAPAMYCIN KINASE; TOR COMPLEX 2;

ANIMAL CELL; ARTICLE; CELL CULTURE; DRUG ACTIVITY; DRUG EFFECT; ENZYME PHOSPHORYLATION; GENE SILENCING; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT; INSULIN SIGNALING; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; ANIMAL; ANTAGONISTS AND INHIBITORS; CYTOLOGY; GENETICS; INSULIN RESISTANCE; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; RNA INTERFERENCE; TRANSPORT AT THE CELLULAR LEVEL;

MAMMALIA;

ANDROSTADIENES; ANIMALS; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; CELLS, CULTURED; GLUCOSE; INSULIN; INSULIN ANTAGONISTS; INSULIN RESISTANCE; LEUCINE; MULTIPROTEIN COMPLEXES; MUSCLE, SKELETAL; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SIROLIMUS; TOR SERINE-THREONINE KINASES;

EID: 84904751608     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-014-1752-9     Document Type: Article

References (41)

1. Balage M, Sinaud S, Prod'homme M, Dardevet D, Vary TC, Kimball SR, Jefferson LS, Grizard J (2001) Amino acids and insulin are both required to regulate assembly of the eIF4E. eIF4G complex in rat skeletal muscle. Am J Physiol Endocrinol Metab 281(3):E565-E574
2. Balage M, Dupont J, Mothe-Satney I, Tesseraud S, Mosoni L, Dardevet D (2011) Leucine supplementation in rats induced a delay in muscle IR/PI3K signaling pathway associated with overall impaired glucose tolerance. J Nutr Biochem 22(3):219-226. doi:10.1016/j.jnutbio.2010.02.001
3. Bernard JR, Liao YH, Hara D, Ding Z, Chen CY, Nelson JL, Ivy JL (2011) An amino acid mixture improves glucose tolerance and insulin signaling in Sprague-Dawley rats. Am J Physiol Endocrinol Metab 300(4):E752-E760. doi:10.1152/ajpendo.00643.2010
4. Bernard JR, Liao YH, Doerner PG 3rd, Ding Z, Hsieh M, Wang W, Nelson JL, Ivy JL (2012) An amino acid mixture is essential to optimize insulin-stimulated glucose uptake and GLUT4 translocation in perfused rodent hindlimb muscle. J Appl Physiol 113(1):97-104. doi:10.1152/japplphysiol.01484.2011
5. Bernard JR, Liao YH, Ding Z, Hara D, Kleinert M, Nelson JL, Ivy JL (2013) An amino acid mixture improves glucose tolerance and lowers insulin resistance in the obese Zucker rat. Amino Acids 45(1):191-203. doi:10.1007/s00726-013-1488- y
6. Bhaskar PT, Hay N (2007) The two TORCs and AKT. Dev Cell 12(4):487-502. doi:10.1016/j.devcel.2007.03.020 (Pubitemid 46523652)
7. Cota D, Proulx K, Smith KA, Kozma SC, Thomas G, Woods SC, Seeley RJ (2006) Hypothalamic mTOR signaling regulates food intake. Science 312(5775):927-930. doi:10.1126/science.1124147 (Pubitemid 43727328)
8. Dodd KM, Tee AR (2012) Leucine and mTORC1: a complex relationship. Am J Physiol Endocrinol Metab 302(11):E1329-E1342. doi:10.1152/ajpendo.00525.2011
9. Doi M, Yamaoka I, Fukunaga T, Nakayama M (2003) Isoleucine, a potent plasma glucose-lowering amino acid, stimulates glucose uptake in C2C12 myotubes. Biochem Biophys Res Commun 312(4):1111-1117 (Pubitemid 37490930)
10. Doi M, Yamaoka I, Nakayama M, Sugahara K, Yoshizawa F (2007) Hypoglycemic effect of isoleucine involves increased muscle glucose uptake and whole body glucose oxidation and decreased hepatic gluconeogenesis. Am J Physiol Endocrinol Metab 292(6):E1683-E1693. doi:10.1152/ajpendo.00609.2006 (Pubitemid 47084704)
11. Floyd JC Jr, Fajans SS, Conn JW, Knopf RF, Rull J (1966) Stimulation of insulin secretion by amino acids. J Clin Invest 45(9):1487-1502. doi:10.1172/JCI105456
12. Goberdhan DC, Ogmundsdottir MH, Kazi S, Reynolds B, Visvalingam SM, Wilson C, Boyd CA (2009) Amino acid sensing and mTOR regulation: inside or out? Biochem Soc Trans 37(Pt 1):248-252. doi:10.1042/BST0370248
13. Greiwe JS, Kwon G, McDaniel ML, Semenkovich CF (2001) Leucine and insulin activate p70 S6 kinase through different pathways in human skeletal muscle. Am J Physiol Endocrinol Metab 281(3):E466-E471
14. Gual P, Le Marchand-Brustel Y, Tanti JF (2005) Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie 87:99-109. doi:10.1016/j.biochi.2004.10.019 (Pubitemid 40298772)
15. Guo K, Yu YH, Hou J, Zhang Y (2010) Chronic leucine supplementation improves glycemic control in etiologically distinct mouse models of obesity and diabetes mellitus. Nutr Metab (Lond) 7:57. doi:10.1186/1743-7075-7-57
16. Hinault C, Mothe-Satney I, Gautier N, Lawrence JC Jr, Van Obberghen E (2004) Amino acids and leucine allow insulin activation of the PKB/mTOR pathway in normal adipocytes treated with Wortmannin and in adipocytes from db/db mice. FASEB J 18(15):1894-1896. doi:10.1096/fj.03-1409fje (Pubitemid 39602275)
17. Hinault C, Van Obberghen E, Mothe-Satney I (2006) Role of amino acids in insulin signaling in adipocytes and their potential to decrease insulin resistance of adipose tissue. J Nutr Biochem 17(6):374-378. doi:10.1016/j. jnutbio.2006.02.008 (Pubitemid 43729348)
18. Houde VP, Brule S, Festuccia WT, Blanchard PG, Bellmann K, Deshaies Y, Marette A (2010) Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue. Diabetes 59(6):1338-1348. doi:10.2337/db09-1324
19. Hresko RC, Mueckler M (2005) mTOR.RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes. J Biol Chem 280:40406-40416. doi:10.1074/jbc.M508361200 (Pubitemid 41780527)
20. Julien LA, Carriere A, Moreau J, Roux PP (2010) mTORC1-activated S6K1 phosphorylates Rictor on threonine 1135 and regulates mTORC2 signaling. Mol Cell Biol 30(4):908-921. doi:10.1128/MCB.00601-09
21. Kalogeropoulou D, Lafave L, Schweim K, Gannon MC, Nuttall FQ (2008) Leucine, when ingested with glucose, synergistically stimulates insulin secretion and lowers blood glucose. Metabolism 57(12):1747-1752. doi:10.1016/j.metabol.2008.09.001
22. Kim J, Guan KL (2011) Amino acid signaling in TOR activation. Annu Rev Biochem 80:1001-1032. doi:10.1146/annurev-biochem-062209-094414
23. Kim SG, Buel GR, Blenis J (2013) Nutrient regulation of the mTOR complex 1 signaling pathway. Mol Cells 35(6):463-473. doi:10.1007/s10059-013-0138-2
24. Kleinert M, Liao YH, Nelson JL, Bernard JR, Wang W, Ivy JL (2011) An amino acid mixture enhances insulin-stimulated glucose uptake in isolated rat epitrochlearis muscle. J Appl Physiol 111(1):163-169. doi:10.1152/japplphysiol. 01368.2010
25. Li Y, Solomon TP, Haus JM, Saidel GM, Cabrera ME, Kirwan JP (2010) Computational model of cellular metabolic dynamics: effect of insulin on glucose disposal in human skeletal muscle. Am J Physiol Endocrinol Metab 298(6):E1198-E1209. doi:10.1152/ajpendo.00713.2009
26. Li X, Wang X, Liu R, Ma Y, Guo H, Hao L, Yao P, Liu L, Sun X, He K, Cao W, Yang X (2013) Chronic leucine supplementation increases body weight and insulin sensitivity in rats on high-fat diet likely by promoting insulin signaling in insulin-target tissues. Mol Nutr Food Res 57(6):1067-1079. doi:10.1002/mnfr.201200311
27. Macotela Y, Emanuelli B, Bang AM, Espinoza DO, Boucher J, Beebe K, Gall W, Kahn CR (2011) Dietary leucine - an environmental modifier of insulin resistance acting on multiple levels of metabolism. PLoS One 6(6):e21187. doi:10.1371/journal.pone.0021187
28. Melnik BC (2012) Leucine signaling in the pathogenesis of type 2 diabetes and obesity. World J Diabetes 3(3):38-53. doi:10.4239/wjd.v3.i3.38
29. Nishitani S, Matsumura T, Fujitani S, Sonaka I, Miura Y, Yagasaki K (2002) Leucine promotes glucose uptake in skeletal muscles of rats. Biochem Biophys Res Commun 299(5):693-696 (Pubitemid 36034542)
30. Petersen KF, Shulman GI (2002) Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus. Am J Cardiol 90(5A):11G-18G (Pubitemid 35266676)
31. Peyrollier K, Hajduch E, Blair AS, Hyde R, Hundal HS (2000) L-Leucine availability regulates phosphatidylinositol 3-kinase, p70 S6 kinase and glycogen synthase kinase-3 activity in L6 muscle cells: evidence for the involvement of the mammalian target of rapamycin (mTOR) pathway in the L-leucine-induced up-regulation of system A amino acid transport. Biochem J 350(Pt 2):361-368
32. Rosner M, Siegel N, Valli A, Fuchs C, Hengstschlager M (2010) mTOR phosphorylated at S2448 binds to raptor and rictor. Amino Acids 38(1):223-228. doi:10.1007/s00726-008-0230-7
33. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM (2005) Phosphorylation and regulation of AKT/PKB by the rictor-mTOR complex. Science 307(5712):1098-1101. doi:10.1126/science.1106148 (Pubitemid 40262113)
34. Sipula IJ, Brown NF, Perdomo G (2006) Rapamycin-mediated inhibition of mammalian target of rapamycin in skeletal muscle cells reduces glucose utilization and increases fatty acid oxidation. Metabolism 55(12):1637-1644. doi:10.1016/j.metabol.2006.08.002 (Pubitemid 44827130)
35. Smith J, Merrick D (2010) Embryonic skeletal muscle microexplant culture and isolation of skeletal muscle stem cells. Methods Mol Biol 633:29-56. doi:10.1007/978-1-59745-019-5-3
36. Tato I, Bartrons R, Ventura F, Luis RJ (2011) Amino acids activate mammalian target of rapamycin complex 2 (mTORC2) via PI3K/Akt signaling. J Biol Chem 286(8):6128-6142. doi:10.1074/jbc.M110.166991
37. Tremblay F, Krebs M, Dombrowski L, Brehm A, Bernroider E, Roth E, Nowotny P, Waldhausl W, Marette A, Roden M (2005) Overactivation of S6 kinase 1 as a cause of human insulin resistance during increased amino acid availability. Diabetes 54(9):2674-2684 (Pubitemid 41233590)
38. Yamamoto N, Sato T, Kawasaki K, Murosaki S, Yamamoto Y (2006) A nonradioisotope, enzymatic assay for 2-deoxyglucose uptake in L6 skeletal muscle cells cultured in a 96-well microplate. Anal Biochem 351(1):139-145. doi:10.1016/j.ab.2005.12.011
39. Yang X, Mei S, Wang X, Li X, Liu R, Ma Y, Hao L, Yao P, Liu L, Sun X, Gu H, Liu Z, Cao W (2013) Leucine facilitates insulin signaling through a Galphai protein-dependent signaling pathway in hepatocytes. J Biol Chem 288(13):9313-9320. doi:10.1074/jbc.M112.409409
40. Yoshizawa F (2012) New therapeutic strategy for amino acid medicine: notable functions of branched chain amino acids as biological regulators. J Pharmacol Sci 118(2):149-155. doi:10.1254/jphs.11R05FM
41. Zhang Y, Guo K, LeBlanc RE, Loh D, Schwartz GJ, Yu YH (2007) Increasing dietary leucine intake reduces diet-induced obesity and improves glucose and cholesterol metabolism in mice via multi-mechanisms. Diabetes 56(6):1647-1654. doi:10.2337/db07-0123 (Pubitemid 46842599)